ArticleCureus2026
Syringe-Assisted Arthroscopic Implantation of Particulated Juvenile Articular Cartilage for Trochlear Cartilage Defects.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Particulated juvenile articular cartilage (PJAC) allograft has emerged as a single-stage biologic option for treatment of focal full-thickness cartilage defects, including isolated trochlear lesions. Open techniques are most commonly described, and although a small number of arthroscopic techniques have been reported, precise placement of particulate graft material within the curved geometry of the trochlea remains technically challenging due to high local shear forces, limited working angles, and difficulty maintaining a dry arthroscopic field. We describe a fully arthroscopic technique for the implantation of PJAC allograft in a trochlear cartilage defect using a standard 1-mL disposable tuberculin syringe to facilitate controlled, titratable graft delivery and uniform particulate distribution. The technique is demonstrated in a representative case and includes defect preparation with creation of stable vertical cartilage shoulders, removal of the calcified cartilage layer, transition to a dry arthroscopic field, syringe-assisted graft placement, and stabilization with fibrin sealant. Syringe-assisted delivery enabled controlled placement of cartilage particulates with uniform distribution under direct arthroscopic visualization, facilitating creation of a thin monolayer flush with the surrounding articular surface. The patient initially progressed through rehabilitation without wound or infectious complications and maintained full knee motion. Postoperative magnetic resonance imaging demonstrated incorporation of the lateral trochlear PJAC implant without delamination or subchondral bone plate disruption. In the setting of a complex prior surgical history, multifocal patellofemoral chondral disease, and persistent activity-related mechanical symptoms, the patient later underwent repeat diagnostic arthroscopy approximately 16 months after PJAC implantation. A standard disposable tuberculin syringe provides a simple, reproducible, and cost-efficient method for improving graft control during arthroscopic PJAC implantation in the trochlea, leveraging widely available instrumentation rather than specialized delivery systems. This technique may help reduce technical barriers to minimally invasive cartilage restoration in anatomically constrained regions of the patellofemoral joint.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.